Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
RNAC
Cartesian Therapeutics Reports Positive Phase 2b Trial Results
| 2024-12-03 |
PHARMACEUTICAL
Cartesian Therapeutics – FDA Grants RMAT Designation for Descartes-08
| 2024-05-22 |
UNITED STATES
